Moreover, the activation of RNA editing of the antizyme inhibitor 1 (AZIN1) in CAFs was revealed to enhance the invasive potential of CAFs in CRC (Takeda et al., 2019). The gene discussed is AZIN1; the disease is colorectal carcinoma.